These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27708270)

  • 1. INPPL1 gene mutations in opsismodysplasia.
    Fradet A; Fitzgerald J
    J Hum Genet; 2017 Feb; 62(2):135-140. PubMed ID: 27708270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects.
    Ghosh S; Huber C; Siour Q; Sousa SB; Wright M; Cormier-Daire V; Erneux C
    Hum Mutat; 2017 Dec; 38(12):1731-1739. PubMed ID: 28869677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia.
    Feist C; Holden P; Fitzgerald J
    Clin Dysmorphol; 2016 Oct; 25(4):152-5. PubMed ID: 27233067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia.
    Vande Catsyne CA; Sayyed SA; Molina-Ortiz P; Moes B; Communi D; Muller J; Heusschen R; Caers J; Azzi A; Erneux C; Schurmans S
    Adv Biol Regul; 2020 May; 76():100651. PubMed ID: 31519471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia.
    Below JE; Earl DL; Shively KM; McMillin MJ; Smith JD; Turner EH; Stephan MJ; Al-Gazali LI; Hertecant JL; Chitayat D; Unger S; Cohn DH; Krakow D; Swanson JM; Faustman EM; Shendure J; Nickerson DA; Bamshad MJ;
    Am J Hum Genet; 2013 Jan; 92(1):137-43. PubMed ID: 23273567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia.
    Iida A; Okamoto N; Miyake N; Nishimura G; Minami S; Sugimoto T; Nakashima M; Tsurusaki Y; Saitsu H; Shiina M; Ogata K; Watanabe S; Ohashi H; Matsumoto N; Ikegawa S
    J Hum Genet; 2013 Jun; 58(6):391-4. PubMed ID: 23552673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHIP2: Structure, Function and Inhibition.
    Thomas MP; Erneux C; Potter BV
    Chembiochem; 2017 Feb; 18(3):233-247. PubMed ID: 27907247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia.
    Huber C; Faqeih EA; Bartholdi D; Bole-Feysot C; Borochowitz Z; Cavalcanti DP; Frigo A; Nitschke P; Roume J; Santos HG; Shalev SA; Superti-Furga A; Delezoide AL; Le Merrer M; Munnich A; Cormier-Daire V
    Am J Hum Genet; 2013 Jan; 92(1):144-9. PubMed ID: 23273569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.
    Sleeman MW; Wortley KE; Lai KM; Gowen LC; Kintner J; Kline WO; Garcia K; Stitt TN; Yancopoulos GD; Wiegand SJ; Glass DJ
    Nat Med; 2005 Feb; 11(2):199-205. PubMed ID: 15654325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
    Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
    Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
    Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second locus for Schneckenbecken dysplasia identified by a mutation in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1).
    Lee H; Nevarez L; Lachman RS; Wilcox WR; Krakow D; Cohn DH;
    Am J Med Genet A; 2015 Oct; 167A(10):2470-3. PubMed ID: 25997753
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
    Eramo MJ; Mitchell CA
    Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
    Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
    Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
    Erneux C; Edimo WE; Deneubourg L; Pirson I
    J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Ibrahim S; Sorisky A
    J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of SRC homology 2-containing inositol 5'-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling.
    Kagawa S; Sasaoka T; Yaguchi S; Ishihara H; Tsuneki H; Murakami S; Fukui K; Wada T; Kobayashi S; Kimura I; Kobayashi M
    J Clin Endocrinol Metab; 2005 May; 90(5):2911-9. PubMed ID: 15687335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.